01 — At a Glance
The Content Dinosaur That Decided to Become a Healthcare AI Startup
- 52-Week High / Low₹3,079 / ₹1,336
- Q3 FY26 Revenue₹182 Cr
- Q3 FY26 PAT₹40.8 Cr
- TTM EPS₹101
- Annualised EPS (Q3 × 4)₹82.9
- Book Value / Share₹287
- Price to Book5.26x
- ROCE40.9%
- ROE30.5%
- Operating Margin32%
Flash Summary: MPS posted Q3 FY26 PAT of ₹40.8 crore (up 0.22% QoQ, which is basically flat). The TTM EPS is ₹101. Stock is up 27% in 5 years but down 47% in the last 12 months—classic value trap material. Then, just as the market was busy writing the obituary, MPS announced it acquired Unbound Medicine (USA) for $16.5M, positioning itself as a healthcare AI platform company. The board called it “transformative.” The market called it a 24% 1-year return drop. You be the judge.
02 — Introduction
From Editing Books to Teaching Doctors: The Pivot Nobody Expected
MPS Ltd is what happens when a company realizes that helping publishers typeset textbooks is a commodity business. So they diversified into learning platforms, eLearning solutions, digital content creation—basically building stuff on top of stuff on top of content. For 15+ years, this worked.
Then the AI explosion hit. And MPS woke up and realized that the future of learning isn’t “content that you pay ₹599 for,” but rather “intelligent platforms that cost hospitals ₹50 lakh annually and save clinicians five hours per week by reducing admin burden.”
Enter: Unbound Medicine. Founded in 1999, it’s a healthcare knowledge management platform trusted by 1,000+ hospitals and 500+ healthcare organizations globally. Revenue: ~$8.88 million in FY24. EBITDA margin: 14%. The platform serves medical professionals, nursing students, and healthcare facilities with clinical lookup tools, drug databases, and interactive learning. MPS just acquired 100% for $16.5 million (~₹138 crores) and immediately started talking about margin expansion, cross-selling through its existing network, and international geographic expansion into Southeast Asia, Middle East, Europe, and Australia.
This is not a short-term play. This is a pivot. And the market absolutely hates uncertainty in pivots—hence the -47% return in 12 months.
What the Q3 numbers won’t tell you: MPS raised ₹42 crores of debt to fund the acquisition. The CFO called it “very comfortable.” The CEO also confirmed in the concall that Unbound’s founder (Bill Detmer) is now a “strategic advisor” at a few hours per week, while the CTO, Sales, Product, and Marketing leadership are all staying. Key talent retention = good signal. Phantom equity given to Unbound management = skin in the game. These are the details that matter more than the headline numbers.
03 — Business Model: WTF Do They Even Do? (Now)
Three Businesses Walking Into a Bar. One Is Losing Relevance.
Members get full access to every article.
